BTG plunks down $314M for Protherics

The UK's BTG has inked a deal to buy Protherics for £218 million ($314 million), forming one of Britain's biggest biotech companies. Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.